Literature DB >> 11918216

Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.

David J Rickard1, Katrina M Waters, Terry J Ruesink, Sundeep Khosla, John A Katzenellenbogen, Benita S Katzenellenbogen, B Lawrence Riggs, Thomas C Spelsberg.   

Abstract

Estrogen induction of progesterone receptor (PR) expression may be important to bone physiology because progesterone has been implicated in the control of bone formation and resorption. Although PR gene expression can be induced in osteoblasts by estrogen signaling through the estrogen receptor (ER) a isoform, it is unknown whether the ER-beta isoform is involved in this regulation. The effect of estrogen on PR expression was examined in human fetal osteoblast (hFOB) cell lines stably transfected with either ER-alpha or ER-beta. Estrogen treatment of hFOB/ER-a cells induced PR messenger RNA (mRNA) steady-state levels after 24 h and protein levels after 48 h, as established by competitive reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. Interestingly, no induction of PR expression was observed in the hFOB/ER-beta cells during this period. However, PR mRNA was induced progressively after 48 h of treatment with estrogen with maximum levels achieved at 12 days posttreatment. ER protein also was increased after 12 days of treatment. Both A and B isoforms of PR (PRA and PRB) were induced by estrogen in the hFOB/ER-a cells as well as much later in hFOB/ER-beta cells. The pure antiestrogen ICI 182,780 prevented PR induction by estrogen in both cell lines. An ER-beta-selective antagonist R, R-tetrahydrochrysene (THC) abolished the induction of PR mRNA in hFOB/ER-beta but not in hFOB/ER-a cells, verifying that the response in the former cell line was ER-beta-mediated. Transient cotransfection of hFOB cells with ER-a or ER-beta together with either a human PRA or PRB promoter linked to a reporter plasmid revealed that although the PRB promoter was stimulated equally by estrogen activation of either ER isoform, PRA was activated preferentially by ER-alpha. Together, these results show that although estrogen can up-regulate endogenous PR gene expression in osteoblasts via both ER isoforms, ER-alpha is the predominant inducer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918216     DOI: 10.1359/jbmr.2002.17.4.580

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

Review 1.  Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

Review 2.  Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

Authors:  J R Hawse; M Subramaniam; J N Ingle; M J Oursler; N M Rajamannan; T C Spelsberg
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

Review 3.  Postmenopausal tibolone therapy: biologic principles and applied clinical practice.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2007-01-03

4.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 5.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

6.  Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.

Authors:  Zhendong A Zhong; Alexander Kot; Yu-An E Lay; Hongliang Zhang; Junjing Jia; Nancy E Lane; Wei Yao
Journal:  J Bone Miner Res       Date:  2017-07-13       Impact factor: 6.741

7.  Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle.

Authors:  Bruno Mozzanega; Salvatore Gizzo; Daniela Bernardi; Luigi Salmaso; Tito Silvio Patrelli; Roberto Mioni; Livio Finos; Giovanni Battista Nardelli
Journal:  J Bone Miner Metab       Date:  2013-03-12       Impact factor: 2.626

8.  Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.

Authors:  John R Hawse; Malayannan Subramaniam; David G Monroe; Amanda H Hemmingsen; James N Ingle; Sundeep Khosla; Merry Jo Oursler; Thomas C Spelsberg
Journal:  Mol Endocrinol       Date:  2008-05-15

9.  Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration.

Authors:  K Gagnidze; Z M Weil; L C Faustino; S M Schaafsma; D W Pfaff
Journal:  J Neuroendocrinol       Date:  2013-10       Impact factor: 3.627

10.  Regulation of progesterone receptor expression by estradiol is dependent on age, sex and region in the rat brain.

Authors:  Princy S Quadros; Christine K Wagner
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.